Skip to main content

Carlos Arteaga, M.D., Named to Susan G. Komen® Research Scholar Group

DALLAS – Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center, has been named a research scholar for Susan G. Komen®, one of the world’s leading breast cancer organizations.

 Carlos L. Arteaga, M.D.

Carlos L. Arteaga, M.D., is Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center.

Dr. Arteaga, Professor of Internal Medicine and the Lisa K. Simmons Distinguished Chair in Comprehensive Oncology at UT Southwestern, is one of nine new “Komen Scholars” who will join nearly 50 distinguished leaders in breast cancer research and advocacy. The group helps guide Komen’s research and scientific programs with a focus on advancing discoveries to improve breast cancer outcomes.

The Komen Scholars, with expertise in areas including breast cancer biology, genomics, biomarkers, health disparities, therapeutics, clinical trials, and imaging, lead Komen’s scientific peer-review process and act as ambassadors for Komen in the U.S. and around the world.

“The Komen Scholars bring their expertise and experience from laboratories, clinics, and as patients. They are incredible assets to the transformative work we’re doing at Komen to accelerate research at a time when there is a critical need to advance personalized medicine to help everyone impacted by breast cancer live longer, healthier lives,” said Jennifer A. Pietenpol, Ph.D., chief scientific advisor at Susan G. Komen.

Dr. Arteaga is internationally recognized for his work in laboratory-based translational research and advancing the care of breast cancer patients. He has earned numerous accolades from the American Cancer Society, the American Association for Cancer Research, Susan G. Komen, the Breast Cancer Research Foundation, and the American Society of Clinical Oncology. 

Other new members named to the Komen Scholars group are: Myles Brown, M.D., Harvard Medical School/Dana-Farber Cancer Institute; Susan Domchek, M.D., University of Pennsylvania/Perelman School of Medicine; David Mankoff, M.D., Ph.D., University of Pennsylvania; Kathy Miller, M.D., Indiana University Melvin and Bren Simon Comprehensive Cancer Center; Harikrishna Nakshatri, B.V.Sc., Ph.D., Indiana University School of Medicine; Jeffrey Rosen, Ph.D., Baylor College of Medicine; Bryan Schneider, M.D., Indiana University School of Medicine; and Antonio Wolff, M.D., FACP, FASCO, Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center.

The Simmons Cancer Center is one of only 53 centers nationwide designated as a Comprehensive Cancer Center by the National Cancer Institute and the only one in North Texas. In 2022, the Simmons Cancer Center was ranked 25th among hundreds of cancer centers in the nation by U.S. News & World Report. Its faculty members treat more than 9,000 new cancer patients a year, participate in more than 300 active clinical trials, and have more than $100 million in extramural cancer-focused research funding.

Dr. Arteaga has received research funding from Susan G. Komen and has previously served as an adviser for the organization.